Vericel Stock

Vericel FCF Yield

The Free Cash Flow Yield of Vericel (VCEL) as of Aug 16, 2026 is 1.42 %. In the previous year, Free Cash Flow Yield was -0.33 % — a change of -525.88% (higher).

FCF Yield

1.42 %

YoY

-525.88%

Last updated:

Free Cash Flow Yield of Vericel is 2026 1.42 % . Free Cash Flow Yield of Vericel was 2025 -0.33 % . It decreases by -525.88% higher compared to the previous year.
Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

Free Cash Flow Yield of Vericel is 1.42 % in 2026.

Free Cash Flow Yield of Vericel changed from -0.33 % to 1.42 %, representing a -525.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Vericel since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Vericel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vericel

All Key Metrics — Vericel